Exagen (XGN) EBT Margin Growth (3y) (2021 - 2026)
Exagen (XGN) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -211.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,356.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -317.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 399.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 135.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 360.00 |
| 10 | Exagen | 181.48 Mn | 156.88 Mn | 12.22 Mn | 1,943.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,943.00 |
| Mar 31, 2026 | 4,574.00 |
| Dec 31, 2025 | 8,974.00 |
| Sep 30, 2025 | 1,619.00 |
| Jun 30, 2025 | 16,728.00 |
| Mar 31, 2025 | 7,462.00 |
| Dec 31, 2024 | 2,675.00 |
| Sep 30, 2024 | 1,840.00 |
| Jun 30, 2024 | 3,050.00 |
| Mar 31, 2024 | 3,534.00 |
| Dec 31, 2023 | -1,330.00 |
| Sep 30, 2023 | -38.00 |
| Jun 30, 2023 | 212.00 |
| Mar 31, 2023 | -918.00 |
| Dec 31, 2022 | -8,464.00 |
| Sep 30, 2022 | -2,719.00 |
| Jun 30, 2022 | -16,628.00 |
| Mar 31, 2022 | -6,963.00 |
| Dec 31, 2021 | -4,465.00 |
| Sep 30, 2021 | -3,626.00 |